Fibrin activation of vascular endothelial cells. Induction of IL-8 expression.
Fibrin deposition and leukocyte accumulation are classic histopathologic hallmarks of acute and chronic inflammation. Although both of these processes are common to inflammatory processes, surprisingly little is known about the interrelationship between fibrin deposition and leukocyte accumulation. We hypothesized that: 1) fibrin can regulate inflammation by directly inducing leukocyte chemotactic factor (LCF) expression from vascular endothelial cells (VEC), and 2) this fibrin-induced VEC expression of LCF would enhance leukocyte recruitment seen in acute and chronic inflammation. To test this hypothesis, we developed an in vitro model system of in situ polymerization of fibrin on isolated bovine pulmonary artery endothelial cells in culture. In the initial phase of our studies, we found that fibrin induced a time- and dose-dependent expression of leukocyte migration activity from VEC. Checkerboard analysis demonstrated that the leukocyte migration activity present in the fibrin-stimulated VEC culture supernatant was truly chemotactic in nature. In an effort to begin to characterize this chemotactic activity, we demonstrated that this fibrin-induced LCF activity was 1) protein dependent, 2) not derived from fibrin(ogen), and 3) had an apparent m.w. of 6 to 12 kDa. Our further studies demonstrated that fibrin was a potent stimulus for IL-8 Ag expression from the VEC. Thus, these studies clearly demonstrate that fibrin has the capability to induce leukocyte chemotactic activity in general, and IL-8 activity specifically, from VEC. These studies support our hypothesis that fibrin is an important activator of vascular endothelial cells in vivo.
Qi
J
J
Department of Pathology, University of Connecticut Health Center, Farmington 06030, USA.
Kreutzer
D L
DL
D000818:Animals; D002417:Cattle; D002465:Cell Movement / Q000187:drug effects; D002478:Cells, Cultured; D002630:Chemotactic Factors / Q000096:biosynthesis; D002634:Chemotaxis, Leukocyte / Q000502:physiology; D017077:Culture Media, Conditioned / Q000494:pharmacology; D004730:Endothelium, Vascular / Q000187:drug effects* / Q000378:metabolism*; D005109:Extracellular Matrix / Q000502:physiology; D016326:Extracellular Matrix Proteins / Q000502:physiology; D005337:Fibrin / Q000494:pharmacology*; D005340:Fibrinogen / Q000302:isolation & purification; D007106:Immune Sera / Q000276:immunology; D016209:Interleukin-8 / Q000096:biosynthesis* / Q000737:chemistry / Q000276:immunology; D007962:Leukocytes / Q000166:cytology; D011402:Pronase / Q000502:physiology; D011651:Pulmonary Artery / Q000187:drug effects / Q000378:metabolism
D002630:Chemotactic Factors; D017077:Culture Media, Conditioned; D016326:Extracellular Matrix Proteins; D007106:Immune Sera; D016209:Interleukin-8; D005337:Fibrin; D005340:Fibrinogen; D011402:Pronase